Ann Acad Med Singap
-
Ann Acad Med Singap · Mar 2023
ReviewAn approach to genetic testing in patients with metastatic castration-resistant prostate cancer in Singapore.
There has been a rapid evolution in the treatment strategies for metastatic castration-resistant prostate cancer (mCRPC) following the identification of targetable mutations, making genetic testing essential for patient selection. Although several international guidelines recommend genetic testing for patients with mCRPC, there is a lack of locally endorsed clinical practice guidelines in Singapore. ⋯ This article aims to provide strategic and implementable recommendations to overcome the challenges in genetic testing for patients with mCRPC in Singapore.